Lexaria Bioscience Corp. — Director's Dealing 2022

Mar 8, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2022-03-08

Reporting Person: McKechnie William Edward (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-03-08	Stock Options	$3.39	A	3400	Acquired	2027-03-08	Common Shares (3400)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
common shares	13191	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$5.31	2026-04-26	Common Shares (1500)	1500	Direct
Stock Options	$7.08	2026-06-08	Common Shares (5000)	6500	Direct
Stock Options	$6.23	2026-09-01	Common Shares (1900)	8400	Direct